Literature DB >> 596963

Bacteremia, endocarditis, and the Hancock valve.

D J Magilligan, E L Quinn, J C Davila.   

Abstract

Among 373 patients with porcine xenografts, there were 27 instances of exposure of the xenograft to bloodstream or endocardial infection in 22 patients. Nine patients underwent 10 separate insertions of xenografts for active infective endocarditis. There were no early infections or valve failures. Three patients returned with a late prosthetic valve endocarditis (PVE) due to a new infection. There were 6 instances of bacteremia early after xenograft valve insertion with no early infection, no valve dysfunction, and 1 instance of late PVE. Eleven patients had PVE on a porcine xenograft. Blood cultures in the 10 patients treated with antibiotics promptly became negative. There were 3 valve-related deaths: 2 from valve incompetence and 1 from mitral and aortic xenograft stenosis. Our experience suggests that the Hancock porcine xenograft is: (1) as resistant to infection as are rigid prostheses in active infective endocarditis; (2) resistant to early postoperative bacteremias; and (3) easier to sterilize than rigid prostheses and more durable than other tissue valves in the face of PVE.

Entities:  

Mesh:

Year:  1977        PMID: 596963     DOI: 10.1016/s0003-4975(10)63449-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Infective endocarditis due to Actinobacillus actinomycetemcomitans in a patient with a porcine prosthetic mitral valve.

Authors:  G Lalonde; R Hand
Journal:  Can Med Assoc J       Date:  1980-02-09       Impact factor: 8.262

2.  Prosthetic valve endocarditis. A survey.

Authors:  M Ben Ismail; N Hannachi; F Abid; Z Kaabar; J F Rougé
Journal:  Br Heart J       Date:  1987-07

3.  Bacteremia following prosthetic valve replacement.

Authors:  F B Parker; C Greiner-Hayes; R H Tomar; A H Markowitz; E L Bove; M A Marvasti
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.